Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypes
Clinical & Translational Immunology · 2026-03 · 15 (3)
DOI: 10.1002/cti2.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 16.03.2026. Verfasst von Paul C Dimayuga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oppenheimer Atherosclerosis Research Center, Department of Cardiology Smidt Heart Institute, Cedars-Sinai Medical Center Los Angeles CA USA. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, Heart Foundation.
Abstract (Originalsprache)
Atherosclerosis is the common underlying pathology in atherosclerotic cardiovascular disease (ASCVD) phenotypes of myocardial infarction (MI), stroke or peripheral artery disease (PAD). Single immune cell profiling of atherosclerotic plaques demonstrates a site‐specific immune profile associated with the ASCVD phenotype, and LL‐37 is a reported autoantigen in atherosclerosis.
Objective
To investigate whether the immune response to LL‐37 would be common among different ASCVD phenotypes.
Methods
Peripheral blood mononuclear cells (PBMCs) and plasma were collected from stable ASCVD patients enrolled within 12 months after MI or stroke or diagnosed with PAD. A subgroup of post‐acute patients provided PBMCs at follow‐up (14.7 ± 3.6 months). T‐cell response to LL‐37 was profiled using activation‐induced markers. LL‐37 IgG, immune complex (IC) levels and subclass were evaluated with ELISA. LDL is a reported binding partner of LL‐37 in plasma. Therefore, cross‐reactivity of LL‐37 IgG‐ICs with native LL‐37 or LL‐37 complexed with LDL (LL‐37_LDL) was assessed using immune depletion.
Results
LL‐37 provokes increased CD4 + CD25 + CD134 + T‐cell response in stable post‐MI patients whereas CD8 + CD25 + CD69 + T cells were reduced in PAD. CD4 + T‐cell response to LL‐37 in post‐MI patients persisted at follow‐up with increased CD4 + CD25 + CD69 + FoxP3 + T regulatory cells while post‐stroke patients had increased CD8 + CD134 + T cells. LL‐37 IgG‐ICs were significantly increased in ASCVD patients with IgG3 subclass reduced in post‐MI compared to post‐stroke. Immune‐depletion showed cross‐reactivity of LL‐37 IgG‐ICs with both native LDL and LL‐37_LDL only in post‐MI plasma.
Conclusion
LL‐37 antigen specific profiling of immune response may differentiate various ASCVD phenotypes and provide mechanistic insight in pathophysiology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oppenheimer Atherosclerosis Research Center, Department of Cardiology Smidt Heart Institute, Cedars-Sinai Medical Center Los Angeles CA USA.
- Barbra Streisand Women's Heart Center, Department of Cardiology Smidt Heart Institute, Cedars-Sinai Medical Center Los Angeles CA USA.
- Department of Biomedical Sciences Cedars-Sinai Medical Center Los Angeles CA USA.
Förderung
- National Institutes of Health
- Heart Foundation
Zitieren
APA
Dimayuga, P. C., Chyu, K. Y., Zhou, J., Zhao, X., Wei, J., Cercek, B., & Shah, P. K. (2026). Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypes. Clinical & Translational Immunology, 15(3). https://doi.org/10.1002/cti2.70083
Vancouver
Dimayuga PC, Chyu KY, Zhou J, Zhao X, Wei J, Cercek B, et al. Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypes. Clinical & Translational Immunology. 2026;15(3). doi:10.1002/cti2.70083
BibTeX
@article{Dimayuga2026,
author = {Dimayuga, Paul C and Chyu, Kuang-Yuh and Zhou, Jianchang and Zhao, Xiaoning and Wei, Janet and Cercek, Bojan and Shah, Prediman K},
title = {Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypes},
journal = {Clinical & Translational Immunology},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cti2.70083}
}
EUVIMED